CONMED Corporation logo
CONMED Corporation CNMD
$ 45.89 -0.18%

Annual report 2025
added 02-17-2026

report update icon

CONMED Corporation Accounts Receivables 2011-2026 | CNMD

Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.
Examples of accounts receivable
  • Customers have not paid invoices for delivered products
  • An advance has been paid to a supplier, but goods have not yet been received
  • Employees have not reported on accountable amounts
  • The government must refund tax overpayments
  • Outstanding loans issued
Importance of accounts receivable in company analysis
  1. Asset quality
    Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment.
  2. Impact on cash flow
    Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages.
  3. Assessment of management efficiency
    The following accounts receivable turnover ratios are commonly used:
    Receivables turnover = Revenue / Average accounts receivable
    (the higher — the better)

    Days Sales Outstanding (DSO) = 365 / Turnover
    (the fewer days — the faster customers pay)

    If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.

Annual Accounts Receivables CONMED Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
248 M 238 M 242 M 191 M 184 M 177 M 189 M 182 M 167 M 148 M 134 M 129 M 140 M 139 M 136 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
248 M 129 M 176 M

Quarterly Accounts Receivables CONMED Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
225 M 234 M 221 M 231 M 239 M 241 M 230 M 229 M 213 M 191 M 197 M - 183 M 184 M 165 M 169 M 164 M 177 M 177 M 177 M 177 M 189 M 189 M 189 M 189 M 182 M 182 M 182 M 182 M 167 M 167 M 167 M 167 M 148 M 148 M 148 M 148 M 134 M 134 M 134 M 134 M 129 M 129 M 129 M 129 M 140 M 140 M 140 M 140 M 139 M 139 M 139 M 139 M 136 M 136 M 136 M 136 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
241 M 129 M 169 M

Accounts Receivables of other stocks in the Medical devices industry

Issuer Accounts Receivables Price % 24h Market Cap Country
Delcath Systems Delcath Systems
DCTH
11.7 M $ 9.11 -10.77 % $ 260 M usaUSA
Acutus Medical Acutus Medical
AFIB
11.4 M - -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
2.37 M - 3.58 % $ 2.21 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
15 M - - $ 475 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
97.3 M $ 13.94 -0.71 % $ 2.09 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
175 M $ 7.0 5.74 % $ 503 M israelIsrael
EDAP TMS S.A. EDAP TMS S.A.
EDAP
18.6 M $ 4.38 -4.58 % $ 163 M franceFrance
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
44.8 M - - $ 3.31 B usaUSA
Avinger Avinger
AVGR
1.01 M - -20.74 % $ 369 K usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
14 M $ 3.49 2.05 % $ 121 M usaUSA
AxoGen AxoGen
AXGN
26.2 M $ 31.87 2.07 % $ 1.47 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
3.26 M - 1.37 % $ 20.5 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
452 M $ 275.33 2.19 % $ 7.77 B usaUSA
BIOLASE BIOLASE
BIOL
5.48 M - -13.19 % $ 166 K usaUSA
Bruker Corporation Bruker Corporation
BRKR
566 M $ 40.88 2.48 % $ 6.09 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
109 K - 37.08 % $ 85.7 M usaUSA
InMode Ltd. InMode Ltd.
INMD
10.5 M $ 14.0 0.29 % $ 905 M israelIsrael
Conformis Conformis
CFMS
9.77 M - - $ 16.4 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
4.71 M $ 14.09 -7.06 % $ 381 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
39.7 M - 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
43.1 M - -10.19 % $ 1.99 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
112 K $ 2.48 1.02 % $ 146 M israelIsrael
Dynatronics Corporation Dynatronics Corporation
DYNT
2.8 M - 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
1.91 M - - $ 10.2 M usaUSA
Electromed Electromed
ELMD
24.7 M $ 24.18 1.09 % $ 204 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
65 M $ 77.41 -1.12 % $ 2.18 B costa-ricaCosta-rica
Second Sight Medical Products Second Sight Medical Products
EYES
455 K - -0.97 % $ 54.4 M usaUSA
GBS GBS
GBS
595 K - -0.57 % $ 7.12 M usaUSA
Globus Medical Globus Medical
GMED
679 M $ 96.27 0.06 % $ 13 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
165 M $ 26.14 0.5 % $ 1.78 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
117 K $ 2.11 -2.76 % $ 1.28 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
272 M $ 11.13 -4.01 % $ 857 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
7.32 M $ 0.73 2.57 % $ 39.7 M usaUSA
Inogen Inogen
INGN
29.6 M $ 6.4 6.53 % $ 151 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
6.73 M $ 1.47 -2.0 % $ 23.7 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
10.6 M $ 102.4 1.89 % $ 1.3 B usaUSA